Abstract

An encouraging approach for the diagnosis and effective therapy of immunological pathologies, which would include cancer, is the identification of proteins and phosphorylated proteins. Disease proteomics, in particular, is a potentially useful method for this purpose. A key role is played by protein phosphorylation in the regulation of normal immunology disorders and targets for several new cancer drugs and drug candidates are cancer cells and protein kinases. Protein phosphorylation is a highly dynamic process. The functioning of new drugs is of major importance as is the selection of those patients who would respond best to a specific treatment regime. In all major aspects of cellular life signalling networks are key elements which play a major role in inter- and intracellular communications. They are involved in diverse processes such as cell-cycle progression, cellular metabolism, cell-cell communication and appropriate response to the cellular environment. A whole range of networks that are involved in the regulation of cell development, differentiation, proliferation, apoptosis, and immunologic responses is contained in the latter. It is so necessary to understand and monitor kinase signalling pathways in order to understand many immunology pathologies. Enrichment of phosphorylated proteins or peptides from tissue or bodily fluid samples is required. The application of technologies such as immunoproteomic techniques, phosphoenrichments and mass spectrometry (MS) is crucial for the identification and quantification of protein phosphorylation sites in order to advance in clinical research. Pharmacodynamic readouts of disease states and cellular drug responses in tumour samples will be provided as the field develops. We aim to detail the current and most useful techniques with research examples to isolate and carry out clinical phosphoproteomic studies which may be helpful for immunology and cancer research. Different phosphopeptide enrichment and quantitative techniques need to be combined to achieve good phosphopeptide recovery and good up- and-down phospho-regulation protein studies.

Highlights

  • Importance of the field The personalized management of diseases has and is being extended and this implies the prescription of specific therapeutics best suited for the individual patient and his/her type of illness

  • We point out the importance of immunology diseases including cancer, especially those which are directly connected to phosphorylated protein kinases and the way in which to isolate and methodologically analyse phosphoproteins-phosphopeptides, with their advantages and disadvantages, when using proteomic tools

  • We aim to detail the current and most useful techniques with research examples to isolate and carry out clinical phosphoproteomic studies which may be helpful for immunology and cancer research

Read more

Summary

Background

Importance of the field The personalized management of diseases has and is being extended and this implies the prescription of specific therapeutics best suited for the individual patient and his/her type of illness. This research study, allowed individual analysis of different pools of phosphorylated peptides using mass spectrometric parameters differentially optimized due to their unique properties They compared the phosphoproteome identified from 120 μg of human mesenchymal stem cells using SIMAC and an optimized titanium dioxide chromatographic method. During the last five years, titanium dioxide (TiO2) has emerged as the most common of the metal oxide affinity chromatography (MOAC) based phosphopeptide enrichment methods This technique offers increased capacity compared to IMAC resins in order to bind and elute mono-phosphorylated peptides.

58. Blaukat A
85. Larsen MR
Findings
92. Biemann K
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call